Council responds after reports London's homeless could be housed here in city
The rising numbers of people rough sleeping and being left homeless is a concern in any city. During its recent budget setting process, Liverpool Council cited the increasing pressure of homelessness on its books, with cash having to be found to support those in need.
This is the case for councils up and down the country, with many relying on temporary accommodation or expensive hotels to house people who have nowhere to go, sometimes through no fault of their own. One such council is Enfield in north London.
The borough is located more than 200 miles away from Liverpool but caused quite a stir in the north west last week as it emerged from national press reports that the council was seeking to buy up dozens of properties in this city region for its own homeless people to be housed in.
READ MORE: Man found dead in car outside pub
READ MORE: Sienna-Rose flight and health update as family 'sobbing with relief'
The news came via a document released in October last year in which the London council's housing and regeneration scrutiny panel was told through its own wholly owned company Housing Gateway, it anticipated purchasing 28 properties 'around the Liverpool area' in the next six months.
A further report in December said it was 'more cost effective' for Enfield to own accommodation than to lease it and would target piloting a scheme here. The documents said: 'This will enable residents to be in the local area where they can seek to find suitable, long-term accommodation.
'Leasing temporary accommodation is a huge cost pressure for Enfield which is not sustainable indefinitely. It is therefore important that Enfield reduce the amount of TA in use.'
However, the borough has now sought to calm fears the London council could be sending more people to take up vital properties in the city. However, it could still consider looking across the wider Liverpool City Region.
An Enfield Council spokesperson said: 'Enfield Council is committed to providing safe, stable, and affordable housing for our residents who are experiencing homelessness. In recent years, the significant shortage of affordable rental homes in Enfield and across London has impacted our ability to place families in suitable homes within the borough.
"This crisis has been worsened by rising rents, a collapsing private rental sector for affordable homes within Local Housing Allowance (LHA) rates, and an increasing number of families and residents facing homelessness. To ensure that residents have access to secure, long-term stable homes, we have taken the difficult but necessary step of looking into the possibility of buying a small number of residential properties in more affordable areas, including the wider Liverpool area, though not in the City of Liverpool.
'At this time, no properties have been acquired in the Liverpool area.' The council said this approach was guided by policy introduced to address the severe shortfall in temporary accommodation and reduce the reliance on costly and unsuitable hotel placements.
The spokesperson added: 'Where possible, we continue to seek housing solutions closer to Enfield. Our focus remains on increasing the supply of affordable homes. We will continue to work with the government to address our borough's housing needs.'
This is not uncommon, however. Councils are often forced to relocate people out of city boundaries where required, for example if they need special types of accommodation or are required support with a pet.
Cllr Sam East, Liverpool Council cabinet member for housing, said since reports emerged, the authority had been working to establish the facts. He said: "The reports were alarming and I understand the concern it's caused – however it's simply not as described.
"Enfield Council have given us a statement that they have no properties in Liverpool, nor any plans to procure them. It appears there is an intention to procure in the wider Merseyside region though, and this may have been mistakenly communicated as Liverpool.
"As a result of our enquiries this week we have already shared information with our neighbouring authorities to support them with this. Out of boundary placements happen, but it can't be right for local authorities to make a policy decision of this nature and move people hundreds of miles routinely. It's another stark symptom of the housing and homelessness crisis in this country, and we will look to work on this across a city region footprint, through the Local Government Association and with the new government."
Despite this, the challenges remain here at home to tackle rough sleeping and homelessness. The trend of rough sleeping in Liverpool ticked upward throughout 2024 when compared to the same period in 2023.
The average number of people seen each night rough sleeping between April and September 2024 was 30, an increase on the average of 22 people seen per night over the same period in 2023. Documents released by the city council last month also set out how an increase in people seeking asylum and prisoners released early risks adding to Liverpool's already climbing rough sleeping figures.
Without mitigation, it is expected that more than £11m in budget pressures could be added to the council's books as a result of the growing homelessness crisis.
The proposals from down south attracted anger from Cllr Carl Cashman, leader of the Liverpool Liberal Democrats. He said: 'In Liverpool, we've already got a temporary accommodation bill for our residents - it's ballooned in size, now it's costing the taxpayers millions every year.
'This isn't kicking the can down the road, this is kicking it across the other side of the country. This is not good for people being moved nor the communities they are being moved to. Imagine the council telling you they'll house you but only if you move over 170 miles away, that's awful and it's going to add even more upheaval to people's lives.
'We need the Labour government to listen to councils. They are being crushed under the weight of mounting costs and we are struggling to get by. We need national funding to launch local initiatives to tackle homelessness in our towns and cities - not just Liverpool but across the country.
'That starts with providing social housing for those that need it in our communities - something the Lib Dems have long called for in Liverpool.'
This prompted a response from Cllr East. He said: "I would gently make two points to the politicians in our city who chose to make sweeping public statements on this issue.
"Firstly, if they had approached me for an understanding of the facts here I would have happily worked with them. We all want to work together on the homelessness crisis.
"Instead they went straight out to make a public statement attacking the city council and no doubt caused undue concern in our communities."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
a day ago
- Yahoo
Market House gets its doors
Thanks to a $44,000 grant award announced in the midst of the 155th anniversary of its construction, the Meadville Market House will soon be in the market for new doors. The current doors don't date back to the time of its construction in 1870, but they are believed to be more than 50 years old, according to Ashley Mattocks-Rose, who chairs the authority that oversees the Market House. 'We couldn't be more excited about it — new roof, new doors,' Mattocks Rose said in a phone interview Friday, recalling another grant announced in April that will provide $560,000 in funding for roof upgrades at the historic structure. 'We just really feel like we've got great momentum right now. It's a really exciting time for Meadville in general and for what the Market House means to Meadville.' The grant to the Market House was among 37 awards announced Thursday by the Pennsylvania Historical & Museum Commission (PHMC). The recipients were selected from a competitive pool of 114 applicants. Each award requires a local match equal to the amount of the grant, according to the announcement. Other recipients in the state's northwestern region included the Erie County historical society, which received $100,000 to repair 96 original wood-framed windows in the historic Watson-Curtze mansion. Venango County will receive $100,000 to replace its courthouse roof. Built in 1868, the building's slate roof is believed to date to approximately 1905. The Oil City Civic Center will receive $15,000 for a new security camera system "We are pleased to support these important projects from across the Commonwealth," said Andrea Lowery, PHMC executive director. "It is rewarding to impact communities in 15 counties. The selected projects beautifully showcase what historic resources Pennsylvanians value – from cornerstone buildings in their downtowns, like a historic market house and a significant industrial complex, to an historic barn. This investment ensures that Pennsylvania's cultural memory will be preserved for future generations." The Market House grant will be supplemented in part with about $15,000 raised through the facility's 2024 Crawford Gives campaign, which specifically highlighted the need for new doors, according to Mattocks-Rose. The Market Authority kicked off the campaign with a parody music video featuring Mattocks-Rose and friend Austin Kulyk. The video, which amassed 10,000 views in less than 24 hours, featured the two singers seated in the building's seated in the main market space with a Market House-themed takeoff of the song 'Love is an Open Door' from the Disney musical 'Frozen.' 'We really need new doors,' the duo sang in the video, which is no longer available on the Market House Facebook page. 'Help us replace our doooooors — historically accurate doors.' Mattocks-Rose said she didn't think the video was part of the authority's grant application, but said another video would likely be part of the strategy for the 2025 Crawford Gives event later this summer. The high cost of replacing the doors results from the need for custom fabrication of doors that are both historically appropriate and secure. Mattocks-Rose said a handicapped accessible entrance is also being considered for the building's northwest corner. A timeline for construction has not yet been determined. The building's 155-year history is the result of extended collective effort, according to Mattock-Rose, and the impending investments in the structure could set the stage for improvements in programming. 'It feels like now is the time to really just ramp this building up,' she said. 'Our job is to make sure that it's open for another 155 years.'
Yahoo
2 days ago
- Yahoo
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced the appointment of Shawn Rose, M.D. Ph.D., as its next Chief Medical Officer (CMO) and Head of Research and Development (R&D) starting on June 23, 2025. He replaces David R. Shook, M.D., who will be stepping down from the role to pursue other opportunities in the oncology space. Dr. Rose has dedicated his career to immunology translational medicine and advancing new treatment options for autoimmune patients. In various leadership roles, he has brought forward more than a dozen programs from discovery into clinical development, and he has developed multiple pioneering approved medicines such as Sotyktu, Stelara, and Tremfya. 'Dr. Rose joins the Nkarta team at a critical threshold as we discover the power of our NK cell platform to treat autoimmune diseases,' said Paul J. Hastings, CEO of Nkarta. 'He is an enterprise leader with a deep clinical background in rheumatology and immunology that's ideally suited to maximize the potential of our allogeneic NK cell platform. Shawn's proven track record as an expert clinician gives me full confidence that he will hit the ground running on day one and meaningfully advance our work in the clinic.' Dr. Rose most recently served as Chief Development Officer, Immunology, at Vividion Therapeutics, working to expand their portfolio by advancing previously undruggable targets in immunology. He also served as interim CMO and Head of Clinical Development at Magenta Therapeutics, working on cell-based therapeutic approaches for patients with cancer, genetic disorders and immune-mediated inflammatory diseases. Dr. Rose also held multiple clinical and development leadership roles at Annexon Biosciences, Janssen Pharmaceuticals, and Bristol-Myers Squibb. He did his postdoctoral research training and clinical training in Internal Medicine and Rheumatology at the Northwestern University Feinberg School of Medicine. 'I am thrilled to join Nkarta to advance innovative cell therapies for patients,' said Dr. Rose. 'I strongly believe that Nkarta's allogeneic NK cell platform has the potential to be a transformational approach for patients with immune-mediated inflammatory disease. I look forward to working closely with Paul and the broader Nkarta team on developing more treatment options for patients.' During the transition, Dr. Rose will work with Dr. Shook, who will remain on as a consultant through July 11. 'Dave was an early pioneer of NK cell therapy while working under Nkarta's scientific founder, Dario Campana, at St. Jude Children's Research Hospital, and he has tirelessly pursued options that were more convenient for patients with safety utmost in mind,' Hastings said. 'Dave has devoted much of his career to make important contributions to the advancement of natural killer cell therapy, leading our early clinical work in cancer and overseeing key aspects of our strategic shift into a new disease area with agility and flexibility. But Dave is a dedicated oncologist, and he has decided to return to the field he loves. He is a fearless advocate for patients and their well-being and a very good friend who will be missed.' About NKX019NKX019 is an allogeneic, cryopreserved, off-the-shelf immunotherapy candidate that uses natural killer (NK) cells derived from the peripheral blood of healthy adult donors. It is engineered with a humanized CD19-directed chimeric antigen receptor (CAR) for enhanced cell targeting and a proprietary, membrane-bound form of interleukin-15 (IL-15) for greater persistence and activity without exogenous cytokine support. CD19 is a biomarker for normal B cells as well as those implicated in autoimmune disease and B cell-derived malignancies. Nkarta is evaluating NKX019 in multiple autoimmune conditions. About NkartaNkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company's website at Cautionary Note on Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as "anticipates," "believes," "expects," "intends," 'plans,' 'potential,' "projects,' 'would' and "future" or similar expressions are intended to identify forward-looking statements. Examples of these forward-looking statements include, but are not limited to, statements concerning Nkarta's expectations regarding any or all of the following: Nkarta's position, plans, strategies, and timelines for the continued and future clinical development and commercial potential of NKX019 (including the future availability and disclosure of clinical data and other updates from Nkarta's clinical trials). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among others: Nkarta's limited operating history and historical losses; Nkarta's lack of any products approved for sale and its ability to achieve profitability; the risk that the results of preclinical studies and early-stage clinical trials may not be predictive of future results; Nkarta's ability to raise additional funding to complete the development and any commercialization of its product candidates; Nkarta's dependence on the clinical success of NKX019; that Nkarta may be delayed in initiating, enrolling patients in or completing its clinical trials; competition from third parties that are developing products for similar uses; Nkarta's ability to obtain, maintain and protect its intellectual property; Nkarta's dependence on third parties in connection with manufacturing, clinical trials and pre-clinical studies; the complexity of the manufacturing process for CAR NK cell therapies; and the success of Nkarta's recent (and any future) cost containment measures. These and other risks and uncertainties are described more fully in Nkarta's filings with the Securities and Exchange Commission ('SEC'), including the 'Risk Factors' section of Nkarta's Annual Report on Form 10-Q for the quarter ended March 31, 2025, filed with the SEC on May 14, 2025, and Nkarta's other documents subsequently filed with or furnished to the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, Nkarta undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Nkarta Media/Investor Contact:Nadir MahmoodNkarta, in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 days ago
- Yahoo
Hilgers Graben and Two Partners Earn Prestigious Chambers USA Honors
Firm receives first Dallas/Fort Worth litigation ranking; partners recognized for government investigations and e-discovery LINCOLN, Neb., June 05, 2025--(BUSINESS WIRE)--National commercial litigation and discovery counsel law firm Hilgers Graben is pleased to announce that the firm and two of its partners have earned recognition from Chambers USA, a guide published by Chambers & Partners that identifies and ranks the best legal talent globally. For the first time, the firm earned a nod for its litigation practice in Dallas/Fort Worth. Firm partner Scott Mascianica again earned recognition for white-collar crime and government investigations in Texas, and partner Rose Hunter Jones was again recognized with a national ranking in e-discovery and information governance. "Scott and Rose exemplify the excellence, integrity and client-centered approach that defines our firm," said firm founder Heather Hilgers. "We are so honored to be recognized by Chambers USA. We're especially proud to see our Dallas litigation team earn its first Chambers ranking." As part of the ranking process, Chambers conducts a rigorous review that includes thousands of peer and reference interviews. One reference described Hilgers Graben as "a tremendous firm" and said the firm is "amazing and so wonderful to work with." Mr. Mascianica is the firm's head of government investigations and regulatory enforcement and a former SEC counsel. He is described by one client, according to Chambers, as "an all-around great lawyer." "Scott has really exceptional technical expertise and experience. He is very well connected and relates to people well," a client told Chambers. Ms. Jones received a highly sought-after Band 2 ranking nationwide for her e-discovery practice. Clients praised her as "impressive and driven." One client told Chambers, "I would highly recommend working with Rose. She takes a unique approach to e-discovery and has specific expertise in the area." Hilgers Graben's Dallas office, led by Grant Schmidt, is known for its sophisticated commercial litigation practice and high-level advocacy on matters nationwide. "We've built a team in Dallas that reflects the firm's core values—delivering elite litigation services with efficiency, responsiveness, and integrity," said Mr. Schmidt. "It's gratifying to see our work recognized by Chambers as we continue to expand our footprint in the region." London-based Chambers and Partners publishes its U.S. guide annually, selecting honorees based on qualities such as technical legal ability, professional conduct, client service, commercial astuteness, diligence and commitment. About Hilgers Graben Hilgers Graben PLLC is a nationwide law firm specializing in complex commercial and IP litigation, government investigations, discovery counsel, corporate and trademark services. The firm combines elite legal talent with common sense business principles to provide high-value legal services while avoiding the billing rate insanity. Hilgers Graben has been named to the Inc. 5000 six times, including in 2024, and recognized as a Best Law Firm by The Best Lawyers in America. The firm is certified by the National Association of Minority & Women Owned Law Firms (NAMWOLF), making it the largest certified women-owned law firm in the nation. View source version on Contacts Media Contact: BeLynn Hollers800-559-4534Belynn@